Italian researchers from the University of Florence have conducted a systematic review and meta-analysis of 75 studies concerning testosterone (T) therapy and cardiovascular (CV) risk.
Symptoms, signs, and laboratory confirmation are all important when determining which patients should try testosterone therapy, according to a panel of experts who shared their views in a Journal of Sexual Medicine commentary.
For men with low testosterone, more severe symptoms of testosterone deficiency syndrome (TDS) could be associated with higher cardiovascular risk, according to Spanish researchers.
On July 2, 2014, Upsher-Smith Laboratories, Inc. announced that Vogelxo™, a testosterone gel, is now available as a generic drug called Testosterone Gel (1%).
Older men who receive intramuscular testosterone injections may not be at higher risk for myocardial infarction (MI), according to a group of researchers from the University of Texas Medical Branch.
A group of Italian researchers feel that compensated (subclinical) hypogonadism should be not considered a new clinical entity, according to a recent report in The Journal of Sexual Medicine.